BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9844117)

  • 1. Complement regulatory proteins in glomerular diseases.
    Nangaku M
    Kidney Int; 1998 Nov; 54(5):1419-28. PubMed ID: 9844117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement regulatory proteins and autoimmunity.
    Kawano M
    Arch Immunol Ther Exp (Warsz); 2000; 48(5):367-72. PubMed ID: 11140463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of human nasal respiratory epithelium from complement-mediated lysis by cell-membrane regulators of complement activation.
    Varsano S; Frolkis I; Rashkovsky L; Ophir D; Fishelson Z
    Am J Respir Cell Mol Biol; 1996 Dec; 15(6):731-7. PubMed ID: 8969267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
    Kim YU; Kinoshita T; Molina H; Hourcade D; Seya T; Wagner LM; Holers VM
    J Exp Med; 1995 Jan; 181(1):151-9. PubMed ID: 7528766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55).
    Holmes CH; Simpson KL; Okada H; Okada N; Wainwright SD; Purcell DF; Houlihan JM
    Eur J Immunol; 1992 Jun; 22(6):1579-85. PubMed ID: 1376264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complement regulatory factors and immunologic recognition mechanism between species].
    Seya T; Matsunoto M
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):637-42. PubMed ID: 8963770
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease.
    Simpson KL; Jones A; Norman S; Holmes CH
    Am J Pathol; 1997 Nov; 151(5):1455-67. PubMed ID: 9358772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
    Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ
    Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cell-associated complement regulatory proteins and their relation to disease processes].
    Seya T
    Rinsho Byori; 1991 Dec; 39(12):1317-24. PubMed ID: 1723433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.
    Harrower TP; Richards A; Cruz G; Copeman L; Dunnett SB; Barker RA
    Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Kidney and complement regulatory factors].
    Matsuo S
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):643-6. PubMed ID: 8963771
    [No Abstract]   [Full Text] [Related]  

  • 12. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).
    Niehans GA; Cherwitz DL; Staley NA; Knapp DJ; Dalmasso AP
    Am J Pathol; 1996 Jul; 149(1):129-42. PubMed ID: 8686736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis.
    Brooimans RA; van Wieringen PA; van Es LA; Daha MR
    Eur J Immunol; 1992 Dec; 22(12):3135-40. PubMed ID: 1280224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis.
    Matsumoto M; Sugita Y; Seya T
    Eur J Immunol; 1991 Aug; 21(8):1787-92. PubMed ID: 1714391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complement regulatory membrane factors in experimental animal models].
    Okada N
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):631-3. PubMed ID: 8963768
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
    Iwata K; Seya T; Ariga H; Nagasawa S
    J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerulonephritis and complement regulatory proteins.
    Nangaku M; Johnson RJ; Couser WG
    Exp Nephrol; 1997; 5(5):345-54. PubMed ID: 9386969
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation.
    Seya T; Hara T; Matsumoto M; Akedo H
    J Immunol; 1990 Jul; 145(1):238-45. PubMed ID: 1694203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells.
    Moutabarrik A; Nakanishi I; Namiki M; Hara T; Matsumoto M; Ishibashi M; Okuyama A; Zaid D; Seya T
    Lymphokine Cytokine Res; 1993 Jun; 12(3):167-72. PubMed ID: 7688580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human complement regulatory proteins expressed on mouse A9 cells containing a human chromosome 1.
    Seya T; Okada M; Hara T; Matsumoto M; Miyagawa S; Oshimura M
    Immunology; 1991 Dec; 74(4):719-24. PubMed ID: 1723716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.